Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009
Completed in 4 days, First Batch of 20,000 doses of Freeze-Dried Solid Phase Synthetic Anti-Mers-CoV Vaccine Is Ready for Testing Today
LONDON, April 30, 2014 /PRNewswire/ — Bioradar UK Ltd. and Replikins Ltd. announced today that the clinical course of the current Mers-CoV outbreak in southeast Asia is 'on course' according to the genomic Replikin Count predictions published on October 10, 2012 and on October 21, 2013.
(Photo: http://photos.prnewswire.com/
Contact:
Samuel Bogoch, MD, PhD
Email
(646) 320-5910